• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

被嗜酸性粒细胞掩盖:伴有IGH重排的儿童B淋巴细胞白血病的隐匿表现

Masked by eosinophils: a cryptic presentation of pediatric B-ALL with IGH rearrangement.

作者信息

Sarda Parimal, Parikh Himil, Shah Sandip, Trivedi Deepa

机构信息

Hemato-Oncology Clinic (HOC) Vedanta, Ground floor, Niramaya Complex, Rajpath Rangoli Road, Ahmedabad, Gujarat, 390054, India.

出版信息

J Hematop. 2025 Jul 14;18(1):33. doi: 10.1007/s12308-025-00649-3.

DOI:10.1007/s12308-025-00649-3
PMID:40658287
Abstract

Hypereosinophilia is uncommon in the pediatric population and may be associated with either primary or secondary conditions. In a very small proportion of cases (less than 1%), it forms part of the initial presentation of acute lymphoblastic leukemia (ALL). More frequently, hypereosinophilia appears before overt leukemia symptoms develop, which can delay diagnosis and place affected children at increased risk due to the lack of early intervention. We recently reviewed a case of 6½-year-old female who presented with hypereosinophilia and no circulating blasts. Bone marrow aspirate showed significant prominence of eosinophils and their precursors with ~ 2% blasts on morphology. Bone marrow biopsy was received for review and showed a significant burden of immature cells/blasts which on immunohistochemistry was revealed as B-acute lymphoblastic leukemia (B-ALL). Cytogenetics by fluorescence in situ hybridization (FISH) showed IGH rearrangement while the routine karyotyping as well as next-generation sequencing (NGS) were both negative for any genetic aberrancy. This case highlights the importance of a thorough marrow evaluation in pediatric eosinophilia and discusses the challenges in identifying cryptic rearrangements that are not evident on standard cytogenetic and molecular panels.

摘要

嗜酸性粒细胞增多症在儿科人群中并不常见,可能与原发性或继发性疾病有关。在极少数病例(不到1%)中,它是急性淋巴细胞白血病(ALL)初始表现的一部分。更常见的情况是,嗜酸性粒细胞增多症在明显的白血病症状出现之前就已出现,这可能会延迟诊断,并由于缺乏早期干预而使患病儿童面临更高的风险。我们最近回顾了一例6岁半的女性病例,该患者表现为嗜酸性粒细胞增多症且外周血无原始细胞。骨髓穿刺显示嗜酸性粒细胞及其前体细胞显著增多,形态学上约有2%的原始细胞。收到骨髓活检结果进行复查,显示有大量未成熟细胞/原始细胞,免疫组化显示为B淋巴细胞急性白血病(B-ALL)。荧光原位杂交(FISH)细胞遗传学检测显示IGH重排,而常规核型分析以及下一代测序(NGS)均未发现任何基因异常。该病例强调了对儿科嗜酸性粒细胞增多症进行全面骨髓评估的重要性,并讨论了在识别标准细胞遗传学和分子检测中不明显的隐匿重排方面所面临的挑战。

相似文献

1
Masked by eosinophils: a cryptic presentation of pediatric B-ALL with IGH rearrangement.被嗜酸性粒细胞掩盖:伴有IGH重排的儿童B淋巴细胞白血病的隐匿表现
J Hematop. 2025 Jul 14;18(1):33. doi: 10.1007/s12308-025-00649-3.
2
Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia.对传统细胞遗传学来说很隐匿:伴有嗜酸性粒细胞增多的费城样急性淋巴细胞白血病。
BMJ Case Rep. 2025 Jan 21;18(1):e259811. doi: 10.1136/bcr-2024-259811.
3
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
4
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Deciphering IGH rearrangement complexity and detection strategies in acute lymphoblastic leukaemia.解析急性淋巴细胞白血病中IGH重排的复杂性及检测策略
NPJ Precis Oncol. 2025 Apr 4;9(1):99. doi: 10.1038/s41698-025-00887-9.
2
Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies.基于RNA的下一代测序融合检测在血液系统恶性肿瘤中的应用
Int J Mol Sci. 2025 Jan 7;26(2):435. doi: 10.3390/ijms26020435.
3
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
伴嗜酸性粒细胞和酪氨酸激酶融合基因的髓系/淋巴肿瘤:一个以新实体为重点的研讨会报告,并进行了包括儿科病例在内的文献复习。
Histopathology. 2023 Dec;83(6):829-849. doi: 10.1111/his.15021. Epub 2023 Aug 8.
4
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.纳拉辛哈:基于靶向RNA测序的新型检测方法,用于鉴定血液系统恶性肿瘤中的嵌合基因融合。
Blood Cancer J. 2020 May 5;10(5):50. doi: 10.1038/s41408-020-0313-6.
5
B-ALL With t(5;14)(q31;q32); Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar -Rearranged B-ALL.伴有t(5;14)(q31;q32)重排及嗜酸性粒细胞增多的B淋巴细胞白血病:一种特殊重排的B淋巴细胞白血病的综合分析
Front Oncol. 2019 Dec 10;9:1374. doi: 10.3389/fonc.2019.01374. eCollection 2019.
6
Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.骨髓活检中造血细胞与 B 淋巴母细胞白血病/淋巴瘤或 B 细胞急性淋巴细胞白血病(B-ALL)的免疫组织化学鉴别:62 例患者研究。
Br J Haematol. 2011 Aug;154(4):466-70. doi: 10.1111/j.1365-2141.2011.08760.x. Epub 2011 Jul 2.